Literature DB >> 29844143

Dynamic Regulation of Cerebral Blood Flow in Patients With Alzheimer Disease.

Rianne A A de Heus1,2, Daan L K de Jong1,2, Marit L Sanders1,2, Gerrita J van Spijker1,2, Madelijn H Oudegeest-Sander1,3,2, Maria T Hopman3, Brian A Lawlor4, Marcel G M Olde Rikkert1,2, Jurgen A H R Claassen5,2.   

Abstract

Cerebral autoregulation and baroreflex sensitivity are key mechanisms that maintain cerebral blood flow. This study assessed whether these control mechanisms are affected in patients with dementia and mild cognitive impairment due to Alzheimer disease, as this would increase the risks of antihypertensive treatment. We studied 53 patients with dementia (73.1 years [95% confidence interval (CI), 71.4-74.8]), 37 patients with mild cognitive impairment (69.2 years [95% CI, 66.4-72.0]), and 47 controls (69.4 years [95% CI, 68.3-70.5]). Beat-to-beat blood pressure (photoplethysmography), heart rate, and cerebral blood flow velocity (transcranial Doppler) were measured during 5-minute rest (sitting) and 5 minutes of orthostatic challenges, using repeated sit-to-stand maneuvers. Cerebral autoregulation was assessed using transfer function analysis and the autoregulatory index. Baroreflex sensitivity was estimated with transfer function analysis and by calculating the heart rate response to blood pressure changes during the orthostatic challenges. Dementia patients had the lowest cerebral blood flow velocity (P=0.004). During rest, neither transfer function analysis nor the autoregulatory index indicated impairments in cerebral autoregulation. During the orthostatic challenges, higher autoregulatory index (P=0.011) and lower transfer function gain (P=0.017), indicating better cerebral autoregulation, were found in dementia (4.56 arb. unit [95% CI, 4.14-4.97]; 0.59 cm/s per mm Hg [95% CI, 0.51-0.66]) and mild cognitive impairment (4.59 arb. unit [95% CI, 4.04-5.13]; 0.51 cm/s per mm Hg [95% CI, 0.44-0.59]) compared with controls (3.71 arb. unit [95% CI, 3.35-4.07]; 0.67 cm/s per mm Hg [95% CI, 0.59-0.74]). Baroreflex sensitivity measures did not differ between groups. In conclusion, the key mechanisms to control blood pressure and cerebral blood flow are not reduced in 2 stages of Alzheimer disease compared with controls, both in rest and during orthostatic changes that reflect daily life challenges.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  baroreflex; blood pressure; cerebrovascular circulation; photoplethysmography; transcranial doppler ultrasonography

Mesh:

Year:  2018        PMID: 29844143     DOI: 10.1161/HYPERTENSIONAHA.118.10900

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  21 in total

1.  Steady-state cerebral autoregulation in older adults with amnestic mild cognitive impairment: linear mixed model analysis.

Authors:  Li Zhang; Evan P Pasha; Jie Liu; Chang-Yang Xing; Danilo Cardim; Takashi Tarumi; Kyle Womack; Linda S Hynan; C Munro Cullum; Rong Zhang
Journal:  J Appl Physiol (1985)       Date:  2020-07-02

Review 2.  Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation.

Authors:  Jurgen A H R Claassen; Dick H J Thijssen; Ronney B Panerai; Frank M Faraci
Journal:  Physiol Rev       Date:  2021-03-26       Impact factor: 37.312

Review 3.  Causes and consequences of baseline cerebral blood flow reductions in Alzheimer's disease.

Authors:  Oliver Bracko; Jean C Cruz Hernández; Laibaik Park; Nozomi Nishimura; Chris B Schaffer
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-14       Impact factor: 6.200

4.  Cerebroarterial pulsatility and resistivity indices are associated with cognitive impairment and white matter hyperintensity in elderly subjects: A phase-contrast MRI study.

Authors:  Soroush H Pahlavian; Xinhui Wang; Samantha Ma; Hong Zheng; Marlena Casey; Lina M D'Orazio; Xingfeng Shao; John M Ringman; Helena Chui; Danny Jj Wang; Lirong Yan
Journal:  J Cereb Blood Flow Metab       Date:  2020-06-05       Impact factor: 6.200

Review 5.  Integrative cerebral blood flow regulation in ischemic stroke.

Authors:  Jui-Lin Fan; Patrice Brassard; Caroline A Rickards; Ricardo C Nogueira; Nathalie Nasr; Fiona D McBryde; James P Fisher; Yu-Chieh Tzeng
Journal:  J Cereb Blood Flow Metab       Date:  2021-07-14       Impact factor: 6.960

6.  Contributions of Cerebral Blood Flow to Associations Between Blood Pressure Levels and Cognition: The Age, Gene/Environment Susceptibility-Reykjavik Study.

Authors:  Justine E Moonen; Behnam Sabayan; Sigurdur Sigurdsson; Mark A van Buchem; Vilmundur Gudnason; Osorio Meirelles; Lenore J Launer
Journal:  Hypertension       Date:  2021-04-19       Impact factor: 9.897

7.  Effects of age and sex on middle cerebral artery blood velocity and flow pulsatility index across the adult lifespan.

Authors:  Mohammed R Alwatban; Stacey E Aaron; Carolyn S Kaufman; Jill N Barnes; Patrice Brassard; Jaimie L Ward; Kathleen B Miller; Anna J Howery; Lawrence Labrecque; Sandra A Billinger
Journal:  J Appl Physiol (1985)       Date:  2021-03-11

8.  Cerebrovascular function and its association with systemic artery function and stiffness in older adults with and without mild cognitive impairment.

Authors:  Tom G Bailey; Timo Klein; Stefan Schneider; Christopher D Askew; Annelise L Meneses; Kayla B Stefanidis; Stefanie Ruediger; Daniel J Green; Tim Stuckenschneider
Journal:  Eur J Appl Physiol       Date:  2022-05-06       Impact factor: 3.346

9.  The short-term effects of sedentary behaviour on cerebral hemodynamics and cognitive performance in older adults: a cross-over design on the potential impact of mental and/or physical activity.

Authors:  Carlijn M Maasakkers; René J F Melis; Roy P C Kessels; Paul A Gardiner; Marcel G M Olde Rikkert; Dick H J Thijssen; Jurgen A H R Claassen
Journal:  Alzheimers Res Ther       Date:  2020-06-22       Impact factor: 6.982

10.  Impaired cerebral autoregulation is associated with poststroke cognitive impairment.

Authors:  Nai-Fang Chi; Han-Hwa Hu; Lung Chan; Cheng-Yen Wang; Shu-Ping Chao; Li-Kai Huang; Hsiao-Lun Ku; Chaur-Jong Hu
Journal:  Ann Clin Transl Neurol       Date:  2020-05-28       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.